GNA14 and nasopharyngeal carcinoma: In addition, we found that patients with low GNA14 expression were less sensitive to chemotherapeutic agents such as 5-fluorouracil and gemcitabine, which are commonly used chemotherapeutic agents in nasopharyngeal carcinoma, suggesting that these patients may have poorer response to chemotherapy.